The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention

Jeffrey Maurice Peters, Yatrik M. Shah, Frank J. Gonzalez

Research output: Contribution to journalReview article

225 Citations (Scopus)

Abstract

Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that are involved in regulating glucose and lipid homeostasis, inflammation, proliferation and differentiation. Although all of these functions might contribute to the influence of PPARs in carcinogenesis, there is a distinct need for a review of the literature and additional experimentation to determine the potential for targeting PPARs for cancer therapy and cancer chemoprevention. As PPAR agonists include drugs that are used for the treatment of metabolic diseases, a more complete understanding of the roles of PPARs in cancer will aid in determining any increased cancer risk for patients undergoing therapy with PPAR agonists.

Original languageEnglish (US)
Pages (from-to)181-195
Number of pages15
JournalNature Reviews Cancer
Volume12
Issue number3
DOIs
StatePublished - Mar 1 2012

Fingerprint

Peroxisome Proliferator-Activated Receptors
Chemoprevention
Carcinogenesis
Neoplasms
Metabolic Diseases
Homeostasis
Transcription Factors
Therapeutics
Ligands
Inflammation
Lipids
Glucose
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

@article{c1e40d4c5e50471da5422b4ee25a1a16,
title = "The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention",
abstract = "Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that are involved in regulating glucose and lipid homeostasis, inflammation, proliferation and differentiation. Although all of these functions might contribute to the influence of PPARs in carcinogenesis, there is a distinct need for a review of the literature and additional experimentation to determine the potential for targeting PPARs for cancer therapy and cancer chemoprevention. As PPAR agonists include drugs that are used for the treatment of metabolic diseases, a more complete understanding of the roles of PPARs in cancer will aid in determining any increased cancer risk for patients undergoing therapy with PPAR agonists.",
author = "Peters, {Jeffrey Maurice} and Shah, {Yatrik M.} and Gonzalez, {Frank J.}",
year = "2012",
month = "3",
day = "1",
doi = "10.1038/nrc3214",
language = "English (US)",
volume = "12",
pages = "181--195",
journal = "Nature Reviews Cancer",
issn = "1474-175X",
publisher = "Nature Publishing Group",
number = "3",

}

The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention. / Peters, Jeffrey Maurice; Shah, Yatrik M.; Gonzalez, Frank J.

In: Nature Reviews Cancer, Vol. 12, No. 3, 01.03.2012, p. 181-195.

Research output: Contribution to journalReview article

TY - JOUR

T1 - The role of peroxisome proliferator-activated receptors in carcinogenesis and chemoprevention

AU - Peters, Jeffrey Maurice

AU - Shah, Yatrik M.

AU - Gonzalez, Frank J.

PY - 2012/3/1

Y1 - 2012/3/1

N2 - Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that are involved in regulating glucose and lipid homeostasis, inflammation, proliferation and differentiation. Although all of these functions might contribute to the influence of PPARs in carcinogenesis, there is a distinct need for a review of the literature and additional experimentation to determine the potential for targeting PPARs for cancer therapy and cancer chemoprevention. As PPAR agonists include drugs that are used for the treatment of metabolic diseases, a more complete understanding of the roles of PPARs in cancer will aid in determining any increased cancer risk for patients undergoing therapy with PPAR agonists.

AB - Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors that are involved in regulating glucose and lipid homeostasis, inflammation, proliferation and differentiation. Although all of these functions might contribute to the influence of PPARs in carcinogenesis, there is a distinct need for a review of the literature and additional experimentation to determine the potential for targeting PPARs for cancer therapy and cancer chemoprevention. As PPAR agonists include drugs that are used for the treatment of metabolic diseases, a more complete understanding of the roles of PPARs in cancer will aid in determining any increased cancer risk for patients undergoing therapy with PPAR agonists.

UR - http://www.scopus.com/inward/record.url?scp=84857641358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84857641358&partnerID=8YFLogxK

U2 - 10.1038/nrc3214

DO - 10.1038/nrc3214

M3 - Review article

C2 - 22318237

AN - SCOPUS:84857641358

VL - 12

SP - 181

EP - 195

JO - Nature Reviews Cancer

JF - Nature Reviews Cancer

SN - 1474-175X

IS - 3

ER -